ABH Healthcare
| Category | Shares reserved | 25-08 | 26-08 | 27-08 | |||
|---|---|---|---|---|---|---|---|
| Shares bid | Times | Shares bid | Times | Shares bid | Times | ||
| QIB | 199,200 | 1,667,304 | 8.37× | 1,667,304 | 8.37× | 1,667,304 | 8.37× |
| NII * | 170,600 | 68,240 | 0.40× | 105,772 | 0.62× | 114,302 | 0.67× |
| ∟bNII (> ₹10L) | 1,018,800 | – | – | – | – | – | – |
| ∟sNII (< ₹10L) | 510,000 | – | – | – | – | – | – |
| Retail | 1,528,800 | 886,704 | 0.58× | 1,360,632 | 0.89× | 1,437,072 | 0.94× |
| Total | 3,602,400 | 2,737,824 | 0.76× | 3,278,184 | 0.91× | 3,386,256 | 0.94× |
| Offer Type | Bookbuilding IPO |
| Sale Type | Fresh capital only |
| Listing At | NSE SME |
| Face Value | ₹ 10 per share |
| Price Band | ₹96 to ₹102 |
| Lot Size | 1200 shares |
| Total Issue Size | 34,29,600 shares (agg. up to ₹ 35 Cr) |
| Category | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 100% | 69.99% |
| Public | 30.01% | |
| Total | 100% | 100% |
| EPS(₹) (pre → post) | 7.05 → 4.93 |
| P/E (x) (pre → post) | 14.47 → 20.69 |
| Market Cap at Offer Price | ₹116.58 Cr |
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 85.27 | 63.90 | 51.35 |
| Total Income | 52.59 | 49.32 | 41.39 |
| Profit After Tax | 5.64 | 5.35 | 1.66 |
| EBITDA | 14.72 | 13.20 | 6.89 |
| NET Worth | 17.27 | 11.60 | 6.30 |
| Reserves and Surplus | 9.34 | 9.69 | 4.35 |
| Total Borrowing | 45.75 | 33.78 | 30.59 |
| ROE | 39.07% |
| ROCE | 19.09% |
| Debt/Equity | 3.20 |
| RoNW | 39.07% |
| PAT Margin | 10.74% |
| EBITDA Margin | 28.03% |
| NAV | 21.58 |
| Price to Book Value | 4.73 |
| Company | Issue price | P/E | Listing-day close |
|---|---|---|---|
| Bio Medica Laboratories Ltd. | ₹139 | 13.03 | ₹115.80 |
| Goldline Pharmaceutical Ltd. | ₹43 | 10.47 | ₹56.77 |
| Speciality Medicines Ltd. | ₹124 | 9.27 | ₹125.90 |
| Accretion Nutraveda Ltd. | ₹129 | 26.27 | ₹191.20 |
| KRM Ayurveda Ltd. | ₹135 | 17.32 | ₹180.70 |
| Curis Lifesciences Ltd. | ₹128 | 12.44 | ₹141.00 |
| Aptus Pharma Ltd. | ₹70 | 11.29 | ₹84.84 |
| Hexagon Nutrition Ltd. | ₹45 | 22.69 | ₹53.19 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 2,400 | ₹2,44,800 |
| Individual investors (IND) (Max) | 2 | 2,400 | ₹2,44,800 |
| S-HNI (Min) | 3 | 3,600 | ₹3,67,200 |
| S-HNI (Max) | 8 | 9,600 | ₹9,79,200 |
| B-HNI (Min) | 9 | 10,800 | ₹11,01,600 |
| Category | Shares | % of issue | Max allottees |
|---|---|---|---|
| QIB | 1,99,200 | 10.49% | 5.53% |
| NII (HNI) | 1,70,600 | 8.99% | 4.74% |
| − bNII > ₹10L | 10,18,800 | 28.28% | |
| − sNII < ₹10L | 5,10,000 | 14.16% | |
| Retail | 15,28,800 | 80.52% | 42.44% |
| Market Maker | 1,72,800 | 4.80% | |
| Total | 36,02,400 | 100.00% | 100.00% |
| Date | GMP ₹ | Implied |
|---|---|---|
| 2026-09-02 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-09-01 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
| 2026-08-31 | 0 | +0.0% |
🏢About ABH Healthcare
ABH Healthcare IPO is a book build issue of ₹34.98 crores. The issue is entirely a fresh issue of 0.34 crore shares of ₹34.98 crore.
ABH Healthcare IPO bidding opened for subscription on Aug 24, 2026 and will close on Aug 27, 2026. The allotment for the ABH Healthcare IPO is expected to be finalized on Aug 28, 2026. ABH Healthcare IPO will list on the NSE SME with a tentative listing date fixed as Sep 1, 2026.
ABH Healthcare IPO is set issue price band at ₹96 to ₹102 per share. The lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,44,800 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹3,67,200.
Fedex Securities Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Rikhav Securities Ltd.
🎯Objects of the Issue
| Object | ₹ Cr |
|---|---|
| Repayment / prepayment, in part or full, of certain of borrowings | 17.00 |
| Funding working capital requirements | 5.00 |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes | – |
- • Fedex Securities Pvt.Ltd.
- • Bigshare Services Pvt.Ltd.
- allotment status is checked on the registrar's portal